JUN 30, 2020 9:00 AM PDT

Quality Control for the Pharmaceutical Industry; Stage 3, Continued Verification, in the Lifecycle of Analytical Procedures

Sponsored by: Sartorius
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Independent Consultant
    Biography
      Jane Weitzel has been working in analytical chemistry for over 40 years for pharmaceutical and mining companies. She is currently a consultant specialising in laboratory management systems, GMP testing, and ISO/IEC 17025. She is an auditor and an educator. Jane has applied Quality Systems and statistical techniques, including the evaluation and use of measurement uncertainty, in a wide variety of technical and scientific businesses. She has obtained the American Society for Quality Certification for both Quality Engineer and Quality Manager.

      Jane was elected to the USP Council of Experts as member of the USP Council of Experts and chair of the 2020-2025 General Chapters-Measurement and Data Quality Expert Committee. She was a member of the USP 2015-2020 Statistics Expert Committee and past member of the USP Expert Panel on Method Validation. She has been Director of pharmaceutical Quality Control laboratories. She has experience with many different regulatory environments.

    Abstract
    DATE:  June 30, 2020
    TIME:   9:00am PDT, 12:00pm EDT
     
    QC laboratories perform a critical role in demonstrating pharmaceutical products are consistently manufactured, safe, potent, and pure. At the same time, the number of tests run by QC laboratories is increasing. QC laboratories need to ensure they are working efficiently and effectively. They have no resources to waste. The analytical control strategy, provided in the lifecycle approach, is a key tool to ensure the analytical procedures are working as expected; the laboratory is not wasting time monitoring variables that are not important; and sources of variability are adequately controlled.
     
    Quality Control (QC) laboratories are responsible for Stage 3 in the lifecycle of analytical procedures, Continued Procedure Performance Verification. In the lifecycle approach, the QC laboratory receives an analytical procedure that has been designed and developed to be fit for use in stage 1, Procedure Design and Development. Procedure Performance Qualification, stage 2, ensures the analytical procedure performs as expected. An output of stages 1 and 2 is the analytical control strategy, which is the understanding and control of sources of variability.
     
    Laboratory instruments, used for weighing and pipetting, and HPLC sample preparation, are included in the analytical procedure and the control strategy. The technique, such as HPLC, is selected during stage 1. Its required performance, such as system suitability, is designed in stage 1, confirmed in stage 2, and is continually verified in stage 3. The uncertainty contributed by the weighing step is estimated in stage 1 and confirmed in stage 2. If the uncertainty is significant, then an adequate control strategy is used, for example, the performance of the balance at a specific weight is confirmed and recorded before use.
     
    The analytical procedure must be fit for its use. This includes meeting the target measurement uncertainty requirement, which is determined in stage 1. If a potential source of variability is a significant contributor to the measurement uncertainty, then a control strategy is needed. A control strategy could be using a system suitability, trending a performance characteristic by using a control chart, providing detailed training to the analyst, including detailed instructions in the operating procedure, or other control mechanisms.
     
    The control strategy can also help the QC laboratory perform efficiently. When an analytical procedure is designed, developed, and qualified with fit for use providing the goal, then steps that do not need special control are also identified. For example, if the uncertainty introduced in a dilution step is not significant, then a less rigorous dilution scheme could be used, saving time and resources.
     
    With the lifecycle approach, the QC laboratory can use an analytical procedure efficiently and effectively. Time and resources will not be wasted. The QC laboratory can confidently defend its performance to any regulatory agency. The test results will support manufacturing. Time will not be lost investigating out of specification results caused by a poorly understood analytical procedure. 
     
    Learning Objectives:
    • The attendee will be able to implement stage 3, continued performance verification, for an analytical procedure.
    • The attendee will be able to determine if an instrument that is used in an analytical procedure is a significant contributor to the measurement uncertainty and requires an operational control in the control strategy.
     
     
    Webinars will be available for unlimited on-demand viewing after live event.
     
    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

    Show Resources
    You May Also Like
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    OCT 08, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    JUN 23, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    Loading Comments...
    Show Resources
    Attendees
    • See more